ATG5 and kidney failure: Genetically modified mice with tamoxifen-induced inhibition of Atg5 in the proximal tubules demonstrated renal failure, the atrophy of kidney tissue, mitochondrial dysfunction, and an increase in oxidative stress products in the kidney [47].